Every round on record, with the sources behind each and the investors on them.
A provider of a semiconductor chip platform for neural devices and brain-computer interfaces
mintneuro.comLinkedInLondon, UKSemiconductorsFounded 2022
6 sources
EU-Startups reports €4.4 million ($5 million), while the company's release states $5 million; the release's figure takes precedence.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $5M | 2026-10-07 | Odyssey | 4 outlets. #36 in Trending |
6 sources [ VERIFIED · CORRECTED ] read against 4 of 6 sources
EU-Startups reports €4.4 million ($5 million), while the company's release states $5 million; the release's figure takes precedence. | ||||
MintNeuro builds purpose-built, low-power semiconductor chips for medical-device companies and researchers to put inside neural devices for sensing, stimulation and signal processing.
Neural implants can be bulky, power-intensive and dependent on invasive surgery, while neurological disorders affect more than one billion people globally; MintNeuro's chips aim to make these devices smaller, lower-power, scalable and less invasive. The October 2026 $5 million round matters because the company says it now has working silicon, integration milestones with Motif Neurotech and Amber Therapeutics, and a multi-year commercial supply agreement with Motif, giving it capital to launch products and support wider adoption.
Checked against 10 sources today
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Funding round | £1 million | 2024-11-12 | Empirical Ventures | |
Also named as backers in company research: Parkwalk Advisors, Imperial College Enterprise Fund, Imperial College London, Plug & Play, Excellis Holding, Advanced Research and Invention Agency (ARIA), Innovate UK, National Institute for Health and Care Research (NIHR)